You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABBV-467

Showing 1 - 25 of 113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma (MM), Cancer Trial in Worldwide (ABBV-467)

Terminated
  • Multiple Myeloma (MM)
  • Cancer
  • ABBV-467
  • Tucson, Arizona
  • +23 more
Jul 20, 2021

Multiple Myeloma Trial in Worldwide (Eftozanermin alfa, Bortezomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Eftozanermin alfa
  • +2 more
  • Atlanta, Georgia
  • +18 more
Oct 12, 2022

Psoriasis Trial in Japan (risankizumab)

Completed
Has Results
  • Psoriasis
  • Nagoya-shi, Aichi, Japan
  • +8 more
Nov 16, 2021

Psoriasis Trial in Canada, Japan, United States (Cedirogant, Placebo)

Recruiting
  • Psoriasis
  • Birmingham, Alabama
  • +54 more
Aug 4, 2022

Crohn's Disease Trial in Worldwide (ABBV-154, Placebo)

Recruiting
  • Crohn's Disease
  • Dothan, Alabama
  • +185 more
Jan 27, 2023

Psoriasis Trial in Worldwide (Risankizumab)

Enrolling by invitation
  • Psoriasis
  • Fountain Valley, California
  • +36 more
Jan 24, 2023

Palmoplantar Pustulosis (PPP) Trial in Japan (Risankizumab, Placebo)

Active, not recruiting
  • Palmoplantar Pustulosis (PPP)
  • Ichinomiya-shi, Aichi, Japan
  • +38 more
Mar 1, 2022

Small Cell Lung Cancer Trial in Worldwide (ABBV-011, Budigalimab)

Recruiting
  • Small Cell Lung Cancer
  • Birmingham, Alabama
  • +32 more
Oct 5, 2022

Healthy Volunteers Trial (ABBV-903)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Oct 5, 2023

ABBV-951 Subcutaneous Infusion to Assess Change in Disease

Not yet recruiting
  • Parkinson's Disease (PD)
    • (no location specified)
    Oct 25, 2023

    Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-927, ABBV-181)

    Active, not recruiting
    • Advanced Solid Tumors Cancer
    • Los Angeles, California
    • +21 more
    Jan 20, 2023

    Acute Myeloid Leukemia Trial (ABBV-787)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 29, 2023

    Subcutaneous Infusion of ABBV-951 to Assess Change in Disease

    Not yet recruiting
    • Parkinson's Disease (PD)
      • (no location specified)
      Jun 15, 2023

      Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-151, Budigalimab)

      Recruiting
      • Advanced Solid Tumors Cancer
      • New Haven, Connecticut
      • +29 more
      Dec 5, 2022

      Healthy Volunteers Trial in Anaheim, Las Vegas (ABBV-552)

      Recruiting
      • Healthy Volunteers
      • Anaheim, California
      • +1 more
      Jan 13, 2023

      B-cell Lymphoma Trial in Israel, Puerto Rico, Turkey (ABBV-623, ABBV-992)

      Terminated
      • B-cell Lymphoma
      • Ramat Gan, Tel-Aviv, Israel
      • +4 more
      Feb 2, 2023

      Upper Limb Spasticity Trial (ABBV-950, BOTOX, Placebo for ABBV-950)

      Not yet recruiting
      • Upper Limb Spasticity
      • ABBV-950
      • +2 more
      • (no location specified)
      Jul 14, 2023

      ABBV-154 Trial in Grayslake, Las Vegas (ABBV-154 Dose Formulation A, ABBV-154 Dose Formulation B)

      Active, not recruiting
      • ABBV-154
      • ABBV-154 Dose Formulation A
      • ABBV-154 Dose Formulation B
      • Grayslake, Illinois
      • +1 more
      Dec 19, 2022

      Dry Eye Syndrome Trial in Azusa (ABBV-444)

      Recruiting
      • Dry Eye Syndrome
      • Azusa, California
        Canyon City Eyecare /ID# 253652
      May 24, 2023

      Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)

      Not yet recruiting
      • Unresectable Metastatic Colorectal Cancer
      • (no location specified)
      Oct 25, 2023

      Healthy Trial (ABBV-CLS-7262)

      Not yet recruiting
      • Healthy
      • (no location specified)
      Nov 17, 2023

      Cystic Fibrosis (CF) Trial in Worldwide (Galicaftor, Placebo, Navocaftor)

      Active, not recruiting
      • Cystic Fibrosis (CF)
      • Mobile, Alabama
      • +46 more
      Oct 20, 2022

      DLBCL, Chronic Lymphocytic Leukemia, B Cell Malignancies Trial in Australia, United States (ABBV-525)

      Not yet recruiting
      • Diffuse Large B-Cell Lymphoma
      • +3 more
      • Louisville, Kentucky
      • +6 more
      Nov 14, 2022

      Relapsed/Refractory Multiple Myeloma Trial in Japan (ABBV-383)

      Recruiting
      • Relapsed/Refractory Multiple Myeloma
      • Kashiwa-shi, Chiba, Japan
      • +5 more
      Jan 25, 2023

      ALS, Amyotrophic Lateral Sclerosis Trial in Canada, United States (ABBV-CLS-7262, Placebo)

      Active, not recruiting
      • ALS
      • Amyotrophic Lateral Sclerosis
      • Irvine, California
      • +13 more
      Jan 20, 2023